Insights from 2023 ASCO® Annual Meeting

 

ecancer
B

ASCO® 2023 Summary: "PanTumor Conference Highlights Including INDIGO, IMbrave050 & TALAPRO-2 Trials"

By ecancer FEATURING Bishal Gyawali
By ecancer FEATURING Bishal Gyawali
211 views
June 27, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh
Basic Science
14:37

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Controlled D…

Insights from 2023 ASCO® Annual Meeting

A. Batra

172 views
47:10

ASCO® 2023 Summary: "PanTumor Conference Highlights Including INDIGO…

ecancer

B. Gyawali

211 views
03:45

ASCO® 2023 Insights: "Risk of Early Mortality in Patients With Cance…

Insights from 2023 ASCO® Annual Meeting

H. Khan

111 views